NCCN Guidelines Insights - Myelodysplastic Syndromes

NCCN Guidelines Insights - Myelodysplastic Syndromes

The goal of the NCCN Guidelines Insights is to educate clinicians on the most up-to-date treatment recommendations, important issues, controversies, recent scientific findings, and the rationale for oncology practice decision-making.

  • Provider:National Comprehensive Cancer Network
  • Activity Link: https://education.nccn.org/Insights2025
  • Start Date: 2025-03-10 05:00:00
  • End Date: 2025-03-10 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: AstraZeneca (Any division) - Amount: 0.0 - Is Kind Support: False Source: Coherus - Amount: 0.0 - Is Kind Support: False Source: Geron - Amount: 0.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 0.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 0.0 - Is Kind Support: False Source: Rigel - Amount: 0.0 - Is Kind Support: False Source: Springworks - Amount: 0.0 - Is Kind Support: False Source: Taiho Pharmaceutical - Amount: 0.0 - Is Kind Support: False
  • Activity Type: Journal-based CE
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.